Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
922
datasets available to search
ShareScore release 0.9.0
Dataset results
922 results for “Chronic lymphocytic leukemia”
Lenalidomide in Treating Patients With High-Risk Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT01271283. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Venetoclax, Rituximab and Ibrutinib in TN Patients With CLL Undetectable Minimal Residual Disease (uMRD) in Treatment-naïve Patients With Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT04758975. IPD Sharing: NO. Countries: 1. Publications: 0.
Banking of Chronic Lymphocytic Leukemia Tumor Cells for Vaccine Generation
ClinicalTrials.gov study NCT00428233. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cyclophosphamide, Alvocidib, and Rituximab in Treating Patients With High Risk B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
ClinicalTrials.gov study NCT01076556. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bendamustine/rituximab Followed by Venetoclax and Rituximab for Treatment of Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT03609593. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase II Study of High-Dose Rituximab in High-Risk Chronic Lymphocytic Leukemia Patients in Suboptimal Response After Induction Immunochemotherapy
ClinicalTrials.gov study NCT01625741. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Combination of Pentostatin, Bendamustine and Ofatumumab for Treatment of Chronic Lymphocytic Leukemia and Lymphoma
ClinicalTrials.gov study NCT01352312. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Zanubrutinib and Venetoclax as Initial Therapy for Chronic Lymphocytic Leukemia (CLL) With Response-based Obinutuzumab
ClinicalTrials.gov study NCT05650723. IPD Sharing: NO. Countries: 1. Publications: 0.
Vaccine Therapy for Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT01976520. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Dasatinib Combination for Chronic Lymphocytic Leukemia(CLL) With Refractory Disease
ClinicalTrials.gov study NCT01051115. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dose-Escalating and Safety Study of CP-461 in Patients With Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00036257. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Assess Change in Patient Experience in Adult Participants With Chronic Lymphocytic Leukemia (CLL) Receiving Oral Venetoclax Tablets + Intravenous Rituximab or Bruton's Tyrosine Kinase Inhib
ClinicalTrials.gov study NCT05555979. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Phase II Study of Vismodegib in Patients With Refractory or Relapsed B-cell Lymphoma or Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT01944943. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Acalabrutinib in Combination With ACP-319, for Treatment of Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT02157324. IPD Sharing: YES. Countries: 1. Publications: 0.
Zanubrutinib in Patients With Waldenström's Macroglobulinemia, Chronic Lymphocytic Leukemia, Marginal Zone Lymphoma and Follicular Lymphoma
ClinicalTrials.gov study NCT05326308. IPD Sharing: NO. Countries: 2. Publications: 0.
The Effects of Exercise on Immune Phenotype of Indolent Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia Patients
ClinicalTrials.gov study NCT05876923. IPD Sharing: Not stated. Countries: 1. Publications: 0.
8-Chloro-Adenosine in Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00714103. IPD Sharing: Not stated. Countries: 1. Publications: 0.
6-Hydroxymethylacylfulvene in Treating Patients With Refractory Myelodysplastic Syndrome, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Blastic Phase Chronic Myelogenous Leukemia
ClinicalTrials.gov study NCT00003997. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Ibrutinib + Obinutuzumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT02537613. IPD Sharing: NO. Countries: 1. Publications: 0.
Vitalis Study - Observational Study on the Quality of Life in Patients Under Treatment for B-Chronic Lymphocytic Leukemia (B-CLL)
ClinicalTrials.gov study NCT00344825. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.